MAP2K7 and breast cancer: Elevated serum hRNase 1 binds to EphA4 and triggers EphA4 signaling in an autocrine/paracrine manner, which in turn promotes breast cancer initiation via the IKK/NF-κB and MEK/Erk activating pathways.